BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 21327253)

  • 1. A simple and fast microfluidic approach of same-single-cell analysis (SASCA) for the study of multidrug resistance modulation in cancer cells.
    Li X; Chen Y; Li PC
    Lab Chip; 2011 Apr; 11(7):1378-84. PubMed ID: 21327253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Same-single-cell analysis for the study of drug efflux modulation of multidrug resistant cells using a microfluidic chip.
    Li X; Ling V; Li PC
    Anal Chem; 2008 Jun; 80(11):4095-102. PubMed ID: 18447319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-cell-kinetics approach to compare multidrug resistance-associated membrane transport in subpopulations of cells.
    Koshkin V; Krylov SN
    Anal Chem; 2011 Aug; 83(16):6132-4. PubMed ID: 21770449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dielectrophoretic Microfluidic Chip Enables Single-Cell Measurements for Multidrug Resistance in Heterogeneous Acute Myeloid Leukemia Patient Samples.
    Khamenehfar A; Gandhi MK; Chen Y; Hogge DE; Li PC
    Anal Chem; 2016 Jun; 88(11):5680-8. PubMed ID: 27149245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quinoline derivative KB3-1 potentiates paclitaxel induced cytotoxicity and cycle arrest via multidrug resistance reversal in MES-SA/DX5 cancer cells.
    Koo JS; Choi WC; Rhee YH; Lee HJ; Lee EO; Ahn KS; Bae HS; Ahn KS; Kang JM; Choi SU; Kim MO; Lu J; Kim SH
    Life Sci; 2008 Nov; 83(21-22):700-8. PubMed ID: 18845169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Same-single-cell analysis using the microfluidic biochip to reveal drug accumulation enhancement by an amphiphilic diblock copolymer drug formulation.
    Khamenehfar A; Wan CP; Li PC; Letchford K; Burt HM
    Anal Bioanal Chem; 2014 Nov; 406(28):7071-83. PubMed ID: 25315452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of P-gp mediated multidrug resistance in-vitro and in-vivo by FG020318.
    Chen LM; Liang YJ; Ruan JW; Ding Y; Wang XW; Shi Z; Gu LQ; Yang XP; Fu LW
    J Pharm Pharmacol; 2004 Aug; 56(8):1061-6. PubMed ID: 15285852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A microfluidic array with cellular valving for single cell co-culture.
    Frimat JP; Becker M; Chiang YY; Marggraf U; Janasek D; Hengstler JG; Franzke J; West J
    Lab Chip; 2011 Jan; 11(2):231-7. PubMed ID: 20978708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and structure-activity relationships of taxuyunnanine C derivatives as multidrug resistance modulator in MDR cancer cells.
    Hasegawa T; Bai J; Dai J; Bai L; Sakai J; Nishizawa S; Bai Y; Kikuchi M; Abe M; Yamori T; Tomida A; Tsuruo T; Hirose K; Ando M
    Bioorg Med Chem Lett; 2007 Jul; 17(13):3722-8. PubMed ID: 17490878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of chemotherapeutic drug resistance in cancer therapy--a quick review.
    Liu FS
    Taiwan J Obstet Gynecol; 2009 Sep; 48(3):239-44. PubMed ID: 19797012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of cancer multidrug resistance by green tea polyphenols.
    Mei Y; Qian F; Wei D; Liu J
    J Pharm Pharmacol; 2004 Oct; 56(10):1307-14. PubMed ID: 15482646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of pO2 on antitumor drug cytotoxicity on MDR and non-MDR variants selected from the LoVo metastatic colon carcinoma cell line.
    Lelong-Rebel I; Brisson C; Fabre M; Bergerat JP; Rebel G
    Anticancer Res; 2008; 28(1A):55-68. PubMed ID: 18383825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal of multidrug resistance in cancer cells by Rhizoma Alismatis extract.
    Fong WF; Wang C; Zhu GY; Leung CH; Yang MS; Cheung HY
    Phytomedicine; 2007 Feb; 14(2-3):160-5. PubMed ID: 16713217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New silicon compounds as resistance modifiers against multidrug-resistant cancer cells.
    Molnar J; Mucsi I; Nacsa J; Hevér A; Gyémánt N; Ugocsai K; Hegyes P; Kiessig S; Gaal D; Lage H; Varga A
    Anticancer Res; 2004; 24(2B):865-71. PubMed ID: 15161039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complete reversal by thaliblastine of 490-fold adriamycin resistance in multidrug-resistant (MDR) human breast cancer cells. Evidence that multiple biochemical changes in MDR cells need not correspond to multiple functional determinants for drug resistance.
    Chen G; Waxman DJ
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1271-7. PubMed ID: 7562498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimultidrug-resistant effect and mechanism of a novel CA-4 analogue MZ3 on leukemia cells.
    Xu D; Fang L; Zhu Q; Hu Y; He Q; Yang B
    Pharmazie; 2008 Jul; 63(7):528-33. PubMed ID: 18717489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid diagnosis of multidrug resistance in cancer by electrochemical sensor based on carbon nanotubes-drug supramolecular nanocomposites.
    Zhang H; Jiang H; Sun F; Wang H; Zhao J; Chen B; Wang X
    Biosens Bioelectron; 2011 Mar; 26(7):3361-6. PubMed ID: 21300536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluoxetine inhibits multidrug resistance extrusion pumps and enhances responses to chemotherapy in syngeneic and in human xenograft mouse tumor models.
    Peer D; Dekel Y; Melikhov D; Margalit R
    Cancer Res; 2004 Oct; 64(20):7562-9. PubMed ID: 15492283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined Fourier transform infrared and Raman spectroscopic approach for identification of multidrug resistance phenotype in cancer cell lines.
    Krishna CM; Kegelaer G; Adt I; Rubin S; Kartha VB; Manfait M; Sockalingum GD
    Biopolymers; 2006 Aug; 82(5):462-70. PubMed ID: 16493658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A search for multidrug resistance modulators: the effects of retinoids in human colon carcinoma cells.
    Bartolini G; Orlandi M; Papi A; Ammar K; Guerra F; Ferreri AM; Rocchi P
    In Vivo; 2006; 20(6A):729-33. PubMed ID: 17203756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.